Trademark: 79353477
Word
CELFTIQAR
Status
Registered
Status Code
700
Status Date
Tuesday, May 30, 2023
Serial Number
79353477
Registration Number
7064546
Registration Date
Tuesday, May 30, 2023
Mark Type
4000
Filing Date
Tuesday, August 23, 2022
Published for Opposition
Tuesday, March 14, 2023

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Sep 25, 2023
Final Decision Transaction Processed By Ib
Sep 3, 2023
Final Disposition Notice Sent To Ib
Sep 3, 2023
Final Disposition Processed
Aug 30, 2023
Final Disposition Notice Created, To Be Sent To Ib
May 30, 2023
Notice Of Registration Confirmation Emailed
May 30, 2023
Registered-Principal Register
Mar 15, 2023
Notification Processed By Ib
Mar 14, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2023
Published For Opposition
Feb 22, 2023
Notification Of Possible Opposition Sent To Ib
Feb 22, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 22, 2023
Notification Of Notice Of Publication E-Mailed
Feb 15, 2023
Refusal Processed By Ib
Feb 9, 2023
Approved For Pub - Principal Register
Feb 1, 2023
Teas/Email Correspondence Entered
Feb 1, 2023
Correspondence Received In Law Office
Feb 1, 2023
Teas Response To Office Action Received
Jan 24, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jan 23, 2023
Refusal Processed By Mpu
Dec 13, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 13, 2022
Teas Change Of Correspondence Received
Dec 13, 2022
Teas Change Of Domestic Representatives Address
Dec 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2022
Teas Change Of Owner Address Received
Nov 16, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Nov 15, 2022
Non-Final Action Written
Nov 8, 2022
Application Filing Receipt Mailed
Nov 7, 2022
Assigned To Examiner
Nov 2, 2022
New Application Office Supplied Data Entered
Nov 1, 2022
Limitation From Original Application Entered
Oct 27, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24